Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task ForceBruno Vellas, Cristina Sampaio, Gordon Wilcock et al.|Alzheimer s & Dementia|2013Cited by 145